首页 | 本学科首页   官方微博 | 高级检索  
检索        

肿节风防治化疗后血小板减少症的研究
引用本文:钟立业,刘天浩,陈运贤,钟雪云,杜欣,陆泽生,翁建宇,吴穗晶,林伟.肿节风防治化疗后血小板减少症的研究[J].中药材,2005,28(1):35-38.
作者姓名:钟立业  刘天浩  陈运贤  钟雪云  杜欣  陆泽生  翁建宇  吴穗晶  林伟
作者单位:1. 广东省人民医院血液内科,广州,510080
2. 中山大学附属第二医院肿瘤科,广州,510120
3. 中山大学附属第一医院血液内科,广州,510080
4. 暨南大学医学院病理教研室,广州,510632
摘    要:目的:探讨肿节风对大剂量化疗后小鼠血小板减少的防治作用.方法:本研究以Babl/c纯系清洁级小鼠为实验对象,通过大剂量5-氟尿嘧啶腹腔注射复制血小板减少的动物模型,用肿节风稀释液从实验开始连续进行灌胃干预,分别在预处理前、化疗前、化疗后第2、第4及第7天测定小鼠血常规;并在化疗后第7天处死小鼠,行骨髓病理活检,观察骨髓造血情况.结果:经过肿节风预处理后,化疗前单药干预组及联合干预组小鼠外周血小板数量显著高于同期对照组(P<0.05),化疗后两个实验组小鼠的血小板数量与对照组相比无显著下降(P<0.05),而两实验组间无显著性差异(P>0.05).骨髓病理检查结果提示,两实验组小鼠骨髓增生活跃,骨髓腔内可见巨核细胞,对照组小鼠骨髓增生低下,未发现巨核细胞.结论:肿节风具有对抗大剂量5-FU所造成的血小板减少的作用,从而预防并治疗化疗后血小板减少症的发生.

关 键 词:血小板减少症  肿节风  化疗
修稿时间:2004年8月19日

The Study on Effect of Sarcandra glabra on Prevention and Treatment of Thrombocytopenia by Chemotherapy
Zhong Liye ,Liu Tianhao ,Chen Yunxian ,Zhong Xueyun ,Du Xin ,Lu Zesheng ,Weng Jianyu ,Wu Suijing ,Lin Wei.The Study on Effect of Sarcandra glabra on Prevention and Treatment of Thrombocytopenia by Chemotherapy[J].Jorunal of Chinese Medicinal Materials,2005,28(1):35-38.
Authors:Zhong Liye  Liu Tianhao  Chen Yunxian  Zhong Xueyun  Du Xin  Lu Zesheng  Weng Jianyu  Wu Suijing  Lin Wei
Institution:The Department of Hematology, Guangdong People' s Hospital, Guangzhou 510080.
Abstract:OBJECTIVE: To investigate the effect of Sarcandra glabra Thunb on prevention and treatment of thrombocytopenia after chemotherapy with a large dosage. METHODS: The Babl/c mice model of thrombocytopenia was made by intraperitoneal injection of 5-FU at a large dosage. All mice were poured Sarcandra glabra Thunb dilution to the mice's stomach once daily from the beginning of the experiment. Then the effect was analyzed by measuring peripheral blood cell counts of the mice on the 2nd day, the 4th day and the 7th day after chemotherapy. On the end of 7th day, all mice were killed, and then bone marrow biopsy was employed to investigate the hemapoietic condition. RESULTS: Before the chemotherapy, the platelet counts of mice treated by Sarcandra glabra Thunb were higher than that in the control group (P < 0.05). After chemotherapy with 5-FU, the platelet counts were not significantly decreased in two all experimental groups compared with negative control group (P < 0.05), while there was not significantly different between two experimental groups (P > 0.05). Moreover the marrow biopsy showed that bone marrow hyperplasia was active in two intervention study groups with some megaryocytes in the medullary cavity of bone while bone marrow hyperplasia was low in the control group without any megaryocyte in the medullary cavity of bone. CONCLUSION: The Sarcandra glabra Thunb had obvious activity in treatment to therombocytopenia and can prevent thrombocytopenia by 5-FU.
Keywords:Thrombocytopenia  Sarcandra  glabra    Thunb  Chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号